Translate page

Collage FlaggenMay 2021 - To get an update on COVID-19 vaccines and CML as well as local perspectives from Brazil and Russia, please join our iCMLf conversations in Portuguese (on Friday) and Russian (on next Monday):

  • iCMLf Conversation on COVID-19 and CML in Portuguese on Friday, May 14th at 8.00 Brazilian Time / 13.00 CET
  • iCMLf Conversation on COVID-19 vaccines and CML in Russian on Monday, May 17th
    at 14.00 Moscow Time / 13.00 CET

Millot EHA 2019April 2021 - Please join us for our next iCMLf Conversation on CML.
Next Tuesday, on April 27th at 13.00 CET, Professor Fréderic Millot will provide an overview of the biological and clinical characteristics of pediatric CML and an update on clinical data and relevant guidelines and recommendations. His main focus during the expert talk will be on treatment-free remission in children with CML.

Update on pediatric CML: Treatment-free remission in children with CML on April 27th at 13.00 CET

  • Professor Fréderic Millot, University of Poitiers (France)

How can I dial into the webinar?

Please join this meeting from your computer, tablet or smartphone:
Meeting-ID: 817 8732 1991

Collage FlaggenApril 2021 - After the successful expert talk in English, we are happy to host a series of iCMLf Conversations on COVID-19 vaccines and CML in different languages over the next couple of weeks.

Please save the date for conversations in Portuguese and Russian.

WorldHealthDay 2020April 2021 - Today is World Health Day! We will continue to do our best to build a fairer, healthier world for patients with CML. During these extraordinary times and current challenges for global health related to COVID-19, our main focus is to support physicians treating patients with CML around the world and to gain and share knowledge about COVID-19 and CML.

The iCMLf is collecting details of CML patients diagnosed with COVID-19. To date we have collected a total number of 642 cases from 48 countries. The iCMLf CML and COVID-19 data was first presented at ASH 2020 and a full publication is expected soon.

We are also putting together a CML vaccination study across sites in 15 countries to assess patients' attitude to being vaccinated, the actual uptake of vaccine by patients, potential side effects/toxicities associated with the vaccines and evidence of immunity by serology. More information will be provided soon.

Wesseling Sweet 2March 2021 - The iCMLf continues to support the global CML community during the pandemic by providing the latest information on COVID-19 and CML. With the increasing availability of COVID-19 vaccines, up to date and relevant information is imperative for physicians treating blood cancers and their patients. The next highlight in our series of iCMLf Conversations is coming up with an expert talk on COVID-19 vaccines and CML to be held Wednesday, April 7th at 13.30 CET.

Don’t miss this opportunity to stay up to date with the latest developments on COVID-19 vaccines for people with CML.

iCMLf Conversation on CML:
Update on COVID-19 vaccines and CML

Date: Wednesday, April 7th at 13.30 Central European Time (CET)

Promotional slide CML 2021 NEWMandelieu La Napoule - NEW DATES: October 7-10, 2021

Chairs: J. Cortes, T.P. Hughes, D.S. Krause

Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.

Deadline for Abstracts: May 8, 2021
Click here to submit your abstract